HoferEL, LabovskyV, La RussaV, ValloneVF, HoneggerAE, BellocCG, WenHC, BordenaveRH, BullorskyEO, FeldmanL and ChasseingNA. (2010). Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow. Stem Cells Dev, 19:359–370.
2.
PanepucciRA, OliveiraLHB, ZanetteDL, Rde Cassia Viu Carrara, AraujoAG, OrellanaMD, de PalmaPVB, MenezesCCBO, CovasDT and ZagoMA. (2010). Increased levels of NOTCH1, NF-κB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells. Stem Cells Dev, 19:321–332.
3.
Jasmin, SprayDC, Campos de CarvalhoAC and Mendez-OteroR. (2010). Chemical induction of cardiac differentiation in P19 embryonal carcinoma stem cells. Stem Cells Dev, 19:403–412.
4.
ZucconiE, VieiraNM, BuenoDF, SeccoM, JazedjeT, AmbrosioCE, Passos-BuenoMR, MiglinoMA and ZatzM. (2010). Mesenchymal stem cells derived from canine umbilical cord vein—a novel source for cell therapy studies. Stem Cells Dev, 19:395–402.
5.
MayaniH. (2010). Biological differences between neonatal and adult human hematopoietic stem/progenitor cells. Stem Cells Dev, 19:285–298.
6.
Pimentel-CoelhoPM and Mendez-OteroR. (2010). Cell therapy for neonatal hypoxic–ischemic encephalopathy. Stem Cells Dev, 19:299–310.
7.
Pimentel-CoelhoPM, ESMagalhães, LMLopes, deAzevedoLC, SantiagoMF and Mendez-OteroR. (2010). Human cord blood transplantation in a neonatal rat model of hypoxic–ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev, 19:351–358.
8.
Bordeaux-RegoP, LuzoA, CostaFF, SaadSTO and Crosara-AlbertoDP. (2010). Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood. Stem Cells Dev, 19:413–422.
9.
BassanezeV, BaraunaVG, Lavini-RamosC, KalilJ, SchettertIT, MiyakawaAA and KriegerJE. (2010). Shear stress induces nitric oxide–mediated vascular endothelial growth factor production in human adipose tissue mesenchymal stem cells. Stem Cells Dev, 19:371–378.
10.
VidaltamayoR, BargasJ, CovarrubiasL, HernándezA, GalarragaE, Gutiérrez-OspinaG and Drucker-ColinR. (2010). Stem cell therapy for Parkinson’s disease: a road map for a successful future. Stem Cells Dev, 19:311–320.
11.
WittigO, Paez-CortezJ and CardierJE. (2010). Liver sinusoidal endothelial cells promote B lymphopoiesis from primitive hematopoietic cells. Stem Cells Dev, 19:341–350.
12.
ResendeRR, da CostaJL, KiharaAH, AdhikariA and LorençonE. (2010). Intracellular Ca2+ regulation during neuronal differentiation of murine embryonal carcinoma and mesenchymal stem cells. Stem Cells Dev, 19:379–394.
13.
Vela-OjedaJ, Montiel-CervantesL, Granados-LaraP, Reyes-MaldonadoE, EGarcía-Latorre, Garcia-ChavezJ, Majluf-CruzA, MayaniH, Borbolla-EscobozaJR and García-Ruiz EsparzaM. (2010). Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation. Stem Cells Dev, 19:333–340.
